Phio Pharmaceuticals (PHIO) Institutional Ownership → Start loving Mondays like this (From DTI) (Ad) Free PHIO Stock Alerts $0.64 0.00 (0.00%) (As of 04/19/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Phio Pharmaceuticals (NASDAQ:PHIO)CurrentInstitutional OwnershipPercentage57.31%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$204.08KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$857.16K Get PHIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Phio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHIO Institutional Buying and Selling by Quarter Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… Phio Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2023Anson Funds Management LP22,571$65K0.0%N/A1.505% 8/10/2023Cetera Investment Advisers10,666$31K0.0%N/A0.711% 8/2/2023Bank of Montreal Can10,000$38K0.0%N/A0.667% 5/12/2023Renaissance Technologies LLC14,280$80K0.0%-91.4%1.241% 5/11/2023Cambridge Investment Research Advisors Inc.14,233$80K0.0%N/A1.237% 2/13/2023Renaissance Technologies LLC166,800$62K0.0%-21.9%14.632% Get the Latest News and Ratings for PHIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Phio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/2022Vanguard Group Inc.218,192$125K0.0%-26.8%1.596% 11/14/2022Renaissance Technologies LLC213,600$122K0.0%-9.0%1.564% 8/13/2022Renaissance Technologies LLC234,849$165K0.0%+465.9%1.719% 8/11/2022Cetera Investment Advisers75,000$53K0.0%-16.7%0.549% 5/13/2022Renaissance Technologies LLC41,500$37K0.0%+310.9%0.304% 5/13/2022Vanguard Group Inc.304,119$269K0.0%+6.8%2.226% 5/13/2022Cetera Investment Advisers90,000$80K0.0%+125.0%0.659% 11/16/2021Cetera Investment Advisers30,000$61K0.0%N/A0.222% 11/9/2021BlackRock Inc.35,592$72K0.0%-17.8%0.263% 9/17/2021Virtu Financial LLC27,110$61K0.0%+74.7%0.200% 8/13/2021Vanguard Group Inc.276,561$625K0.0%+125.4%2.043% 8/12/2021Dimensional Fund Advisors LP23,960$54K0.0%-31.2%0.177% 5/19/2021Virtu Financial LLC15,522$42K0.0%N/A0.115% 5/14/2021Dimensional Fund Advisors LP34,808$93K0.0%+38.3%0.257% 5/12/2021Geode Capital Management LLC87,501$234K0.0%+330.6%0.647% 5/10/2021GSA Capital Partners LLP132,333$355K0.1%+30.5%0.978% 3/26/2021Susquehanna International Group LLP12,058$32K0.0%N/A0.085% 3/8/2021Dimensional Fund Advisors LP25,177$68K0.0%N/A0.178% 2/25/2021Dimensional Fund Advisors LP25,177$68K0.0%N/A0.178% 2/4/2021GSA Capital Partners LLP101,401$273K0.0%+376.6%1.754% 12/11/2020Virtu Financial LLC35,929$77K0.0%N/A0.622% 11/6/2020GSA Capital Partners LLP21,278$46K0.0%N/A0.368% 7/16/2020Wedbush Securities Inc.33,374$73K0.0%N/A0.577% 5/15/2020Sabby Management LLC255,194$452K0.2%N/A8.901% 5/12/2020JPMorgan Chase & Co.21,681$38K0.0%N/A0.755% 2/14/2020UBS Group AG45,409$427K0.0%+43.3%6.997% (Data available from 1/1/2016 forward) PHIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHIO shares? During the previous two years, the following institutional investors and hedge funds held shares of Phio Pharmaceuticals shares: Vanguard Group Inc. ($125K), Renaissance Technologies LLC ($80K), Cambridge Investment Research Advisors Inc. ($80K), Anson Funds Management LP ($65K), and Bank of Montreal Can ($38K), Cetera Investment Advisers ($31K).Learn more on PHIO's institutional investors. What percentage of Phio Pharmaceuticals stock is owned by institutional investors? 57.31% of Phio Pharmaceuticals stock is owned by institutional investors. Learn more on PHIO's institutional investor holdings. Which institutional investors have been buying Phio Pharmaceuticals stock? The following institutional investors have purchased Phio Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($224.75K), Cetera Investment Advisers ($60.67K), Anson Funds Management LP ($22.57K), Vanguard Group Inc. ($19.24K), Cambridge Investment Research Advisors Inc. ($14.23K), and Bank of Montreal Can ($10K). How much institutional buying is happening at Phio Pharmaceuticals? Institutional investors have bought a total of 351,461 shares in the last 24 months. This purchase volume represents approximately $429.10K in transactions. Which Phio Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Phio Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($220.57K), Vanguard Group Inc. ($79.78K), and Cetera Investment Advisers ($15K). How much institutional selling is happening at Phio Pharmaceuticals? Institutional investors have sold a total of 315,348 shares in the last 24 months. This volume of shares sold represents approximately $942.82K in transactions. Related Companies: SXTP Institutional Ownership BCEL Institutional Ownership ARAV Institutional Ownership RNAZ Institutional Ownership NBY Institutional Ownership AGRX Institutional Ownership NOVN Institutional Ownership ARDS Institutional Ownership SNOA Institutional Ownership CYTO Institutional Ownership This page (NASDAQ:PHIO) was last updated on 4/20/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTiny Biotech Stock Wins $75 Billion PatentBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phio Pharmaceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.